In 2019, the MDMA Therapy Training Program launched a series of trainings to prepare therapy providers to become eligible to work on an MDMA-assisted psychotherapy for PTSD protocol.
The training team is currently taking time to focus on program development to support the growth and evolution of the training program for future practitioners. Dates and tuition fees for the 2020 training year will be announced through the Training Program Newsletter once they are scheduled.
Sites in the U.S. and U.S. territories interested in being considered to participate in an Expanded Access MDMA/PTSD protocol may now apply with MAPS Public Benefit Corporation (MAPS PBC) to assess eligibility and obtain the prerequisite training to administer MDMA-assisted psychotherapy. The basic requirements of a qualified site are 1) treatment facility conducive to MDMA-assisted psychotherapy, 2) therapy team, qualified and able to complete MDMA Therapy Training Program, and 3) prescribing physician who can obtain a DEA Schedule I license for MDMA. MAPS PBC is in discussions to select the first 10 sites for the first 50 Expanded Access subjects. Additional subjects and EA sites will depend on discussions with FDA and are unlikely to be approved for another year or so.
Additional site and practitioner requirements are posted on the MAPS PBC website. Each site must submit one site questionnaire and all applicants interested in training need to complete a therapy training application for providers. Only applicants affiliated with a qualifying site can be considered for training at this time. MAPS PBC will review applications on an ongoing basis, as they are received. The MAPS PBC Therapy Provider Connect Portal is a community discussion forum for therapy providers, physicians and facilities to connect with one another to develop a site or treatment staff, in order to become eligible to participate in a MAPS PBC Expanded Access MDMA/PTSD protocol.